Skip to main content
PCVX logo

PCVX · Vaxcyte, Inc. · Analyst Estimates

Track PCVX — free
$56.48 +0.43 (+0.77%) At close · Oct 2
Market Cap
$8.36B
Shares
148.81M
Volume · Oct 2 2.4M Avg daily vol (3M) 1.15M

Analyst Estimates

Compare analyst forecasts for Vaxcyte, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 05:03 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-9.41
-8.19714
-6.19
—
-8.19714
-8.48286
-8.19714
-8.48286
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-11.65
-7.21714
-4.96
—
-7.21714
-7.42143
-7.21714
-7.42143
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
0
87145780
620012000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.7
-2.13857
-1.67
—
-2.13857
-2.16429
-2.13857
-2.16429
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
4
4
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.87
-2.05
-0.86
—
-2.05
-2.12143
-2.05
-2.12143
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
2
2
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 1649094 CUSIP 92243G108 13F (30d) 8 filings 8 filers Visit website Investor relations